An astonishing factoid from the Lechleiter interview: no company has more than a 2% share of the Chinese pharma market. Obviously, there will be a lot of consolidation in the coming years. Thanks for posting the video.
The Global Demographic Tailwind, which manifests itself via escalating sales of branded generics in emerging markets, has become the most important growth driver for the global pharmaceutical industry.
Market Data 
Markets 
AI
